Scarica l'app Stockscreener
6.49
0.76%
-0.05
Precedente Chiudi:
$6.54
Aprire:
$6.55
Volume 24 ore:
351.08K
Relative Volume:
1.08
Capitalizzazione di mercato:
$175.71M
Reddito:
$348.67M
Utile/perdita netta:
$-22.75M
Rapporto P/E:
-7.572
EPS:
-0.8571
Flusso di cassa netto:
$-21.60M
1 W Prestazione:
+1.41%
1M Prestazione:
-7.29%
6M Prestazione:
-8.33%
1 anno Prestazione:
-0.61%
Intervallo 1D:
$6.405
$6.64
Intervallo di 1 settimana:
$6.365
$6.72
Portata 52W:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Nome
Inogen Inc
Settore
Industria
Telefono
805-562-0500
Indirizzo
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.49 | 177.07M | 348.67M | -22.75M | -21.60M | -0.8571 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Iniziato | B. Riley Securities | Buy |
| 2025-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-02-15 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Downgrade | Needham | Buy → Hold |
| 2023-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Aggiornamento | Needham | Hold → Buy |
| 2021-11-02 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Downgrade | Needham | Buy → Hold |
| 2020-05-06 | Reiterato | Needham | Buy |
| 2019-11-06 | Aggiornamento | Needham | Hold → Buy |
| 2019-09-13 | Reiterato | Piper Jaffray | Overweight |
| 2019-08-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Downgrade | Stifel | Buy → Hold |
| 2019-08-07 | Downgrade | Needham | Buy → Hold |
| 2019-06-28 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Reiterato | Needham | Strong Buy |
| 2019-02-27 | Reiterato | Needham | Strong Buy |
| 2018-11-20 | Aggiornamento | Needham | Buy → Strong Buy |
| 2018-11-07 | Reiterato | Needham | Buy |
| 2018-09-10 | Downgrade | Needham | Strong Buy → Buy |
| 2018-08-22 | Ripresa | Stifel | Buy |
| 2018-08-08 | Reiterato | Needham | Strong Buy |
| 2018-06-06 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Reiterato | Needham | Strong Buy |
| 2018-02-28 | Reiterato | Needham | Strong Buy |
Mostra tutto
Inogen Inc Borsa (INGN) Ultime notizie
[144] Inogen Inc SEC Filing - Stock Titan
Q3 2025 Inogen Inc Earnings Call Transcript - GuruFocus
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Yahoo Finance
Inogen Earnings Call: International Strength Amid U.S. Strain - TipRanks
What Inogen (INGN)'s -1.25% Decline Means for Investors 2026-05-18Wave Equality - thelegaladvocate.com
Inogen stock (US45780L1044): respiratory player in focus after Q1 2026 update and restructuring plan - AD HOC NEWS
Inogen, IncCommon Stock (NQ: INGN - The Chronicle-Journal
Inogen (INGN) Q1 2026 Results Miss Estimates — EPS $-0.30 vs $-0.29Earnings Decline Risk - thelegaladvocate.com
Number of shareholders of Inogen, Inc. – FWB:6IO - TradingView
Inogen Q1 2026 slides: revenue beats amid profitability pressure By Investing.com - Investing.com Nigeria
Inogen Q1 2026 slides: revenue beats amid profitability pressure - Investing.com
Earnings call transcript: Inogen’s mixed Q1 2026 results with revenue beat - Investing.com Nigeria
Needham Upgrades Inogen (INGN) - MSN
How The Inogen (INGN) Story Is Shifting With New Targets And Execution Questions - Yahoo Finance
Here's why you should retain Inogen stock in your portfolio for now - MSN
Inogen, Inc. (NASDAQ:INGN) Q1 2026 Earnings Call Transcript - Insider Monkey
Inogen (INGN) TTM Loss Narrows To US$22.7 Million Testing Bearish Profitability Narratives - Sahm
Inogen Inc. Earnings Call Highlights Transition Phase - TipRanks
Inogen (NASDAQ: INGN) Q1 2026 revenue rises 3% as net loss widens - Stock Titan
Inogen Inc stock (US45780L1044): Q1 revenue growth and valuation debate - AD HOC NEWS
INGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin Improves - sharewise.com
Q1 2026 Inogen Inc Earnings Call Transcript - GuruFocus
Inogen, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Inogen Q1 2026 presentation shows revenue beat, widening losses By Investing.com - Investing.com Canada
Inogen (INGN) Reports Strong Q1 Revenue Growth - GuruFocus
Inogen: Q1 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Inogen Q1 2026 shows revenue beat, EPS miss - Investing.com UK
Inogen Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Inogen Q1 2026 shows revenue beat, EPS miss By Investing.com - Investing.com South Africa
Inogen Q1 2026 presentation shows revenue beat, widening losses - Investing.com
Inogen (INGN) Q1 2026 Earnings Transcript - The Globe and Mail
Inogen (NASDAQ:INGN) Q1 2026 Earnings: Revenue Beat Masks Guidance Miss, Stock Dips - ChartMill
Inogen (INGN) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Inogen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Inogen, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-05-07 - Seeking Alpha
Inogen : Supplemental Financials Q1 2026 - marketscreener.com
Inogen (Nasdaq: INGN) Q1 2026 revenue up 3.4% as losses widen - Stock Titan
Inogen Announces First Quarter 2026 Financial Results - marketscreener.com
Why Inogen (INGN) deserves a spot in every portfolio (Buying Pressure) 2026-05-07Float Adjusted Cap - thelegaladvocate.com
The moat Inogen (INGN) is building for long term dominance (Smart Money Active) 2026-05-06Investment Signal Network - newser.com
Here's Why You Should Add Inogen Stock to Your Portfolio Now - MSN
Inogen Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Inogen Inc Azioni (INGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inogen Inc Azioni (INGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wright Mary E | VP, Chief Accounting Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
7,506 |
0 |
20,284 |
| Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off |
Mar 01 '26 |
Option Exercise |
0.00 |
25,017 |
0 |
33,699 |
| Ramade Gregoire | Chief Commercial Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
13,005 |
0 |
50,251 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Mar 01 '26 |
Option Exercise |
0.00 |
14,005 |
0 |
28,283 |
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
42,007 |
0 |
100,949 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '26 |
Option Exercise |
0.00 |
58,346 |
0 |
147,973 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '25 |
Option Exercise |
0.00 |
31,566 |
0 |
50,189 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '25 |
Option Exercise |
0.00 |
28,334 |
0 |
100,108 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Sep 01 '25 |
Option Exercise |
0.00 |
18,135 |
0 |
20,821 |
0.59%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):